Iquest KRX:262840KOSDAQ
아이퀘스트 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked0since Sep 11
In Q2 2026, Iquest reported revenue of ₩10.3bn, down 2.0% year on year, and operating profit of ₩870m. Iquest (아이퀘스트) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Iquest quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩10.3bn | -2.0% | ₩870m | ₩1.1bn |
| Q1 2026 | ₩10.5bn | +7.6% | ₩634m | ₩5.8bn |
| Q4 2025 derived | ₩11.4bn | +1.6% | ₩1.3bn | ₩2.0bn |
| Q3 2025 | ₩11.8bn | +3.9% | ₩926m | ₩776m |
| Q2 2025 | ₩10.6bn | +21.3% | ₩1.0bn | ₩799m |
| Q1 2025 | ₩9.8bn | +4.7% | ₩1.0bn | ₩2.4bn |
| Q4 2024 derived | ₩11.3bn | +0.2% | ₩1.9bn | ₩2.2bn |
| Q3 2024 | ₩11.3bn | +13.5% | ₩1.5bn | ₩2.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Iquest top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Iquest news Korean headlines
No articles yet.